Violation of Business Ethics in the Professionality of Marketing Children's Syrup Medicine (Literatur Review)

Abstract

The mysterious cases of acute kidney failure in children currently spreading in Indonesia are suspected to be caused by a mixture of syrup compounds, namely ethylene glycol and diethylene glycol. Ethylene glycol and diethylene glycol are chemicals that should not be present in drug mixtures. If consumed orally, they can cause harmful effects to the body. Adding additional solvents to syrups for children constitutes dishonest behavior, deceiving consumers, because they are not listed on the drug's composition label. This dishonesty can cause illness and even death in children. Violations of business ethics such as these constitute actions and/or actions that harm consumers. The Indonesian Food and Drug Authority (BPOM) has taken legal action against the pharmaceutical company that committed this case for producing drugs with very high levels of ethylene glycol, exceeding the threshold. The company faces a 10-year prison sentence and a Rp 1 billion fine. However, the situation should not stop there. The Food and Drug Authority (BPOM) must conduct stricter oversight of all drug and food manufacturers to ensure the safety of all consumers. In this article, the author will examine the issue of "Violations of business ethics in the professional marketing of children's syrup medication" using a literature review method based on published articles from journals and other scientific publications.